Interpace Biosciences, Inc. (IDXG)

Healthcare · Medical Devices · Price $7.57
Updated: Sep 1, 2026
Excellent Equity Returns — Healthcare
ROE of 142.98% — above the 20% excellent threshold Zyberno applies to Healthcare businesses.
ROE
142.98%
Return on Equity
ROIC
12.51%
Return on Invested Capital
ROA
85.91%
Return on Assets
Debt/Equity
0.27x
Leverage Ratio
Book Value/Share
$0.84
Equity Per Share

🧮 IDXG ROE Calculation

ROE = Net Income / Shareholders' Equity
Net Income (TTM) $24.4M
Shareholders' Equity $23.2M
Total Debt $6.3M
Debt-to-Equity Ratio 0.27x
ROE (Return on Equity) 142.98%

Understanding ROE

Return on Equity (ROE) measures how efficiently a company generates profits from shareholders' equity. For IDXG, the current ROE is 142.98%.

Why ROE Matters

Warren Buffett has called ROE one of his favorite metrics because it shows how well management uses shareholders' capital to generate returns. A company that consistently earns 15%+ ROE is typically a well-run business that creates value for shareholders.

ROE Benchmarks

Excellent: >20%

Exceptional returns on equity. Often indicates strong competitive advantages. Common in capital-light businesses.

Good: 15-20%

Above-average ROE. Buffett often looks for companies in this range or higher.

Average: 10-15%

Typical for most companies. Returns are reasonable but not exceptional.

Below Average: <10%

May indicate poor capital allocation or challenging business conditions.

The DuPont Analysis

ROE can be decomposed into three components using DuPont analysis:

ROE = Net Margin × Asset Turnover × Equity Multiplier

This breakdown reveals whether high ROE comes from high profitability (good), efficient asset use (good), or high leverage (potentially risky).

ROE vs ROIC: Which is Better?

ROIC: 12.51% →

ROIC measures returns on ALL capital. It's more comprehensive and less affected by leverage. Often considered the better quality metric.

ROE: 142.98%

ROE only measures returns on equity. Can be inflated by high debt. If ROE >> ROIC, the company uses significant leverage.

Owner Earnings: $4.5M →

Shows actual cash available to owners. Use alongside ROE and ROIC for complete analysis.

Net Income: $24.4M →

The numerator in ROE. Understanding net income trends helps explain ROE changes over time.

What to Look For

📊 Full IDXG Stock Report

Intrinsic value, margin of safety, DCF valuation, and 250+ metrics.

🏆 IDXG ROIC

Compare ROE to ROIC — the more comprehensive measure of capital efficiency.

💹 IDXG P/E Ratio

Analyze valuation relative to earnings and understand market pricing.

👤 IDXG Owner Earnings

Warren Buffett's preferred measure of true economic earnings available to owners.

💰 IDXG Net Income

See the earnings that drive ROE calculations.

💵 IDXG Free Cash Flow

Actual cash generation after capital expenditures.

View Full IDXG Report Find More Quality Stocks
📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$1.69
🛡️
Margin of Safety
Valuation Gap
-100.0%
🎯
Expected Return
Projected Annual
-2.9%
Click any metric for full methodology and detailed analysis

Summary: IDXG Return on Equity

Interpace Biosciences, Inc. (IDXG) has a ROE of 142.98%, which Zyberno classifies as excellent for a Healthcare company — above the 20% threshold Zyberno applies to healthcare companies where IP and regulatory advantages drive equity returns. With a debt-to-equity ratio of just 0.27x, Zyberno notes these returns are being generated with minimal leverage — a particularly strong signal of underlying business quality. For complete financial analysis, view the full IDXG stock report on Zyberno.

Frequently Asked Questions

What is IDXG's current ROE?

Interpace Biosciences, Inc.'s Return on Equity (ROE) is 142.98%, measured against the 20% excellent threshold Zyberno applies to Healthcare businesses. ROE measures the company's profitability relative to shareholders' equity.

Is IDXG's ROE good?

Interpace Biosciences, Inc. (IDXG) has a ROE of 142.98%, which Zyberno classifies as excellent for a Healthcare company — above the 20% threshold Zyberno applies to healthcare companies where IP and regulatory advantages drive equity returns.

What is the difference between ROE and ROIC?

ROE measures returns on shareholder equity only, while ROIC measures returns on all invested capital (debt + equity). IDXG's ROE is 142.98% vs ROIC of 12.51%. ROE can be inflated by high debt, making ROIC often a more reliable quality metric.

Can high ROE be misleading?

Yes, high ROE can be misleading if achieved through high debt. IDXG's debt-to-equity ratio is 0.27x. Compare ROE to ROIC — if ROE is much higher than ROIC, the company uses significant leverage which adds risk.

📊 Full IDXG Stock Report

See IDXG's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

🏆 IDXG ROIC

Compare to Return on Invested Capital — the most comprehensive measure of capital efficiency.

💹 IDXG P/E Ratio

Analyze the price-to-earnings ratio and earnings yield as a valuation metric.

🎯 IDXG Earnings Surprise (SUE)

See whether IDXG is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

👤 IDXG Owner Earnings

Warren Buffett's preferred measure of true economic earnings available to owners.

💰 IDXG Net Income

See the bottom-line profit that drives return calculations.

📊 IDXG EPS

Earnings per share — net income on a per-share basis.

View Full IDXG Report Find More Quality Stocks
Scroll to Top